HEK293-based production platform for γ-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNA

Human gene therapy. Clinical development

Volumn 25, Issue 4, 2014, Pages 218-228

  Hennig, Katharina ^a   Raasch, Lars ^a   Kolbe, Carolin ^a   Weidner, Sibylle ^a   Leisegang, Matthias ^a   Uckert, Wolfgang ^a   Titeux, Matthias ^a   Hovnanian, Alain ^a   Kuehlcke, Klaus ^a   Loew, Rainer ^a  

^a BIONTECH AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COL7A1 PROTEIN, HUMAN; COLLAGEN TYPE 7; RECOMBINANT DNA;

GAMMARETROVIRUS; GENE TARGETING; GENE VECTOR; GENETIC ENGINEERING; GENETICS; HEK293 CELL LINE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PROCEDURES;

COLLAGEN TYPE VII; DNA, RECOMBINANT; GAMMARETROVIRUS; GENE TARGETING; GENETIC ENGINEERING; GENETIC VECTORS; HEK293 CELLS; HUMANS;

EID: 84937511839     PISSN: None     EISSN: 23248645     Source Type: Journal    
DOI: 10.1089/humc.2014.083     Document Type: Article

References (0)